SAN FRANCISCO — In this video from the American Academy of Orthopaedic Surgeons Annual Meeting, Robert V. O’Toole, MD, FAAOS, discussed results from several trials on infection and outcomes after fracture surgery.
O’Toole, a professor of orthopedic trauma at the University of Maryland School of Medicine and the chief of orthopedics at the R Adams Cowley Shock Trauma Center at the University of Maryland Medical Center, spoke about results from the VANCO trials that analyzed the efficacy of vancomycin powder for reducing deep surgical site infection (SSI) and gram-positive deep SSI